Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone.


Tissue deposits of amyloid may lead to various clinical symptoms and signs, depending on the site of deposition. In addition, a specific subtype of amyloidosis, AL protein type, is associated with multiple myeloma. Two cases representing contrasting examples of altered radiopharmaceutical biodistribution in myeloma and amyloidosis are presented and… (More)


  • Presentations referencing similar topics